Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
2017 ◽
Vol 18
(12)
◽
pp. 1637-1651
◽
Keyword(s):
Phase 3
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 16
(7)
◽
pp. 859-870
◽
Keyword(s):
2019 ◽
Vol 20
(3)
◽
pp. 420-435
◽